Camici et al: IVIG treatment for Long COVID, a case report
- Condition
- Long COVID
- At worst
- Severe (mostly bedbound)
- Ill for
- Not stated
- Published
- Jul 2026
Summary
This previously healthy 39-year-old man received a course of IVIG (intravenous immunoglobulin) for Long COVID after other multidisciplinary interventions had failed to help, though the forum thread does not reproduce the specific dose, number of infusions, or regimen length from the original case report. He had developed a "highly symptomatic" post-COVID condition with disabling fatigue, cognitive dysfunction and autonomic symptoms. Improvements were noted starting from his first infusion, and by one year his fatigue score had normalized, his neurocognitive performance returned to normal, and his quality of life improved, which the thread describes as "full recovery." Whether the recovery was sustained beyond that one-year mark or required any maintenance dosing is not stated.
Similar stories
-
Dr Chia finds enterovirus ME/CFS patients given remdesivir remain in remission (Teodora)
A long COVID patient with associated enterovirus involvement. A Paxlovid course produced remarkable reductions in pain and improved energy, but stopping it triggered a horrendous symptomatic rebound. A later molnupiravir course gave only modest benefit by…
-
Radical Rest and Beyond
The author of Encephalogirl (who signs as Michelle) treats her ME/CFS-related dysautonomia and POTS with guanfacine and low-dose Abilify (titrated from 0.5mg down to 0.25mg after migraines, then back up to 0.5mg), an increased dose of low-dose naltrexone, a…
-
Treat ME Survey Results 2
Subcutaneous immunoglobulin (SCIG), given alongside a fecal microbiota transplant, for just over a year at time of report. Before treatment he was severely unwell, underweight at 118 pounds, and unable to attend school, with comorbid POTS and mast cell…
-
[Case study] CFS/ME remission story severe patient [2008]
Treeman describes his daughter reaching roughly 85% function on weekly Cuvitru immunoglobulin, with IgG levels rising from 4.7 to 9.1 and persistent shingles/IBS improving by 3 months. He says gains faded after a subsequent infection, with recovery from that…